Found 72 matching trials
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery PHASE2 The standard treatment for locally advanced rectal cancer involves chemothe...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer PHASE2 This is a multicenter, single-arm, phase II study of nivolumab in combinati...
Show More Status
Active Not Recruiting
Location
Institut Jules Bordet
Learn More & Join Trial
SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC PHASE3 To explore the efficacy and safety of an intensified treatment regimen cons...
Show More Location
Sixth Affiliated Hospital, Sun Yat-sen University
Learn More & Join Trial
Quality of Life in Patients With Rectal Cancer Receiving Total Mesorectal Excision With or Without Stoma N/A The goal is to evaluate whether the renunciation of a diverting stoma in pa...
Show More Learn More & Join Trial
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery PHASE2 RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. D...
Show More Location
Institut Bergonie
Learn More & Join Trial
Rectal Cancer CTC Trial NA This prospective, multi-centre, randomised clinical trial aims to compare t...
Show More Location
University Hospital Olomouc
Learn More & Join Trial
Rectal Cancer, Adjuvant Chemotherapy, FOLFOX(5-fluorouracil/Leucovorin/Oxaliplatin), Total Mesorectal Excision PHASE2 The introduction of total mesorectal excision (TME) and the progress of neo...
Show More Location
Severance Hospital
Learn More & Join Trial
Efficacy of Neoadjuvant Folfirinox Regimen in Patients With Resectable Locally Advanced Rectal Cancer PHASE3 National, multi-center, open-label,randomized, 2-arm phase III superiority ...
Show More Location
Centre hospitalier Universitaire d'Amiens
Learn More & Join Trial
Induction Chemotherapy for MRF-negative, Moderate-risk, Resectable Middle and Low Rectal Cancer PHASE2 This study is designed to test the Safety and efficacy of induction and ind...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Efficacy and Safety of Conventional Neoadjuvant Therapy Versus Total Neoadjuvant Therapy in Older Patients With Locally Advanced Rectal Cancer NA The SHAPERS study is a multicentre, open-label, randomised, pragmatic clini...
Show More Learn More & Join Trial